Grape King Bio Ltd (1707.TW)
TWD 151.0
(0.0%)
TWD 151.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 10.63 Billion TWD | 2.33% |
| 2022 | 10.39 Billion TWD | 6.05% |
| 2021 | 9.79 Billion TWD | 6.87% |
| 2020 | 9.16 Billion TWD | -0.77% |
| 2019 | 9.23 Billion TWD | 0.61% |
| 2018 | 9.18 Billion TWD | -2.18% |
| 2017 | 9.38 Billion TWD | 2.21% |
| 2016 | 9.18 Billion TWD | 26.73% |
| 2015 | 7.24 Billion TWD | 15.36% |
| 2014 | 6.28 Billion TWD | 11.15% |
| 2013 | 5.65 Billion TWD | 22.57% |
| 2012 | 4.61 Billion TWD | 22.29% |
| 2011 | 3.77 Billion TWD | 14.89% |
| 2010 | 3.28 Billion TWD | 16.32% |
| 2009 | 2.82 Billion TWD | 33.58% |
| 2008 | 2.11 Billion TWD | 24.11% |
| 2007 | 1.7 Billion TWD | 14.26% |
| 2006 | 1.48 Billion TWD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 2.75 Billion TWD | 17.35% |
| 2024 Q1 | 2.34 Billion TWD | -26.6% |
| 2023 Q2 | 2.66 Billion TWD | 20.05% |
| 2023 Q1 | 2.21 Billion TWD | -28.95% |
| 2023 Q4 | 3.19 Billion TWD | 25.44% |
| 2023 Q3 | 2.55 Billion TWD | -4.28% |
| 2023 FY | 10.63 Billion TWD | 2.33% |
| 2022 Q3 | 2.49 Billion TWD | -8.47% |
| 2022 FY | 10.39 Billion TWD | 6.05% |
| 2022 Q2 | 2.72 Billion TWD | 32.64% |
| 2022 Q1 | 2.05 Billion TWD | -29.67% |
| 2022 Q4 | 3.12 Billion TWD | 25.38% |
| 2021 Q3 | 2.4 Billion TWD | -4.01% |
| 2021 FY | 9.79 Billion TWD | 6.87% |
| 2021 Q1 | 1.97 Billion TWD | -28.1% |
| 2021 Q2 | 2.5 Billion TWD | 26.96% |
| 2021 Q4 | 2.91 Billion TWD | 21.43% |
| 2020 Q1 | 2 Billion TWD | -25.96% |
| 2020 Q3 | 2.16 Billion TWD | -3.57% |
| 2020 Q4 | 2.74 Billion TWD | 26.52% |
| 2020 Q2 | 2.24 Billion TWD | 11.91% |
| 2020 FY | 9.16 Billion TWD | -0.77% |
| 2019 FY | 9.23 Billion TWD | 0.61% |
| 2019 Q3 | 2.11 Billion TWD | -12.03% |
| 2019 Q2 | 2.4 Billion TWD | 19.21% |
| 2019 Q1 | 2.01 Billion TWD | -24.5% |
| 2019 Q4 | 2.71 Billion TWD | 28.49% |
| 2018 Q1 | 1.93 Billion TWD | -30.65% |
| 2018 Q4 | 2.66 Billion TWD | 20.05% |
| 2018 Q3 | 2.22 Billion TWD | -5.94% |
| 2018 FY | 9.18 Billion TWD | -2.18% |
| 2018 Q2 | 2.36 Billion TWD | 22.23% |
| 2017 Q3 | 2.24 Billion TWD | -4.63% |
| 2017 Q1 | 2 Billion TWD | -20.75% |
| 2017 Q2 | 2.35 Billion TWD | 17.44% |
| 2017 Q4 | 2.78 Billion TWD | 24.15% |
| 2017 FY | 9.38 Billion TWD | 2.21% |
| 2016 Q1 | 2 Billion TWD | -0.08% |
| 2016 FY | 9.18 Billion TWD | 26.73% |
| 2016 Q4 | 2.52 Billion TWD | 10.08% |
| 2016 Q3 | 2.29 Billion TWD | -2.29% |
| 2016 Q2 | 2.35 Billion TWD | 17.01% |
| 2015 Q2 | 1.85 Billion TWD | 12.56% |
| 2015 Q1 | 1.65 Billion TWD | -6.1% |
| 2015 FY | 7.24 Billion TWD | 15.36% |
| 2015 Q4 | 2.01 Billion TWD | 16.32% |
| 2015 Q3 | 1.72 Billion TWD | -6.98% |
| 2014 Q3 | 1.51 Billion TWD | -7.55% |
| 2014 Q2 | 1.63 Billion TWD | 17.55% |
| 2014 Q1 | 1.38 Billion TWD | -8.37% |
| 2014 FY | 6.28 Billion TWD | 11.15% |
| 2014 Q4 | 1.75 Billion TWD | 16.41% |
| 2013 Q4 | 1.51 Billion TWD | 9.16% |
| 2013 Q2 | 1.51 Billion TWD | 23.7% |
| 2013 FY | 5.65 Billion TWD | 22.57% |
| 2013 Q1 | 1.22 Billion TWD | -6.25% |
| 2013 Q3 | 1.38 Billion TWD | -8.54% |
| 2012 Q3 | 1.16 Billion TWD | 0.23% |
| 2012 Q2 | 1.15 Billion TWD | 9.79% |
| 2012 Q1 | 1.05 Billion TWD | 6.09% |
| 2012 FY | 4.61 Billion TWD | 22.29% |
| 2012 Q4 | 1.3 Billion TWD | 12.81% |
| 2011 Q2 | 966.59 Million TWD | 8.32% |
| 2011 Q1 | 892.37 Million TWD | -9.69% |
| 2011 Q4 | 994.51 Million TWD | 8.39% |
| 2011 FY | 3.77 Billion TWD | 14.89% |
| 2011 Q3 | 917.53 Million TWD | -5.08% |
| 2010 Q4 | 988.15 Million TWD | 17.18% |
| 2010 FY | 3.28 Billion TWD | 16.32% |
| 2010 Q3 | 843.28 Million TWD | 1.53% |
| 2010 Q2 | 830.59 Million TWD | 33.92% |
| 2010 Q1 | 620.23 Million TWD | 0.0% |
| 2009 FY | 2.82 Billion TWD | 33.58% |
| 2008 FY | 2.11 Billion TWD | 24.11% |
| 2007 FY | 1.7 Billion TWD | 14.26% |
| 2006 FY | 1.48 Billion TWD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Standard Chem & Pharm CO., LTD. | 6.23 Billion TWD | -70.407% |
| Maywufa Company Ltd. | 1.3 Billion TWD | -717.469% |
| ScinoPharm Taiwan, Ltd. | 3.18 Billion TWD | -233.732% |
| Lotus Pharmaceutical Co., Ltd. | 16.95 Billion TWD | 37.298% |
| LIWANLI Innovation Co., Ltd. | 38.88 Million TWD | -27243.297% |
| YungShin Global Holding Corporation | 7.02 Billion TWD | -51.296% |
| PhytoHealth Corporation | 162.48 Million TWD | -6443.82% |
| SCI Pharmtech, Inc. | 1.2 Billion TWD | -783.022% |
| Formosa Laboratories, Inc. | 4.36 Billion TWD | -143.851% |
| PharmaEssentia Corporation | 5.1 Billion TWD | -108.261% |
| Bora Pharmaceuticals Co., LTD. | 14.2 Billion TWD | 25.12% |